DEFINITIONS Flashcards

1
Q

ACETULCHOLINE (Ach)

A

A CHEMICAL PRODUCED BY THE BODY THAT IS USED IN THE TRANSMISSION OF THE NERVE IMPULSES. IT DESTROYED BY THE ENZYME CHOLINESTERASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADRENERGIC (ADRENOMIMETIC)

A

REFERS TO A DRUG STIMULATING A RECEPTOR FOR NOREEPINEPHRINE OR EPINEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AFFERENT

A

SIGNALS THAT ARE TRANSMITTED TO THE BRAIN AND SPINAL CORD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AGONIST

A

A CHEMICAL OR DRUG THAT BINDS TO A RECEPTOR AND CREATES AN EFFECT ON THE BODY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ANTAGONIST

A

ACHEMICAL OR A DRUG THAT BINDS TO A RECEPTOR BUT DOES NOT CREATE AN EFFECT ON THE BODY IT ACTUALLY BLOCKS THE RECEPTOR SITE FROM ACEPTNG AN AGONIST.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ANTICHOLINERGIC

A

REFERS TO A DRUG BLOCKING A RECEPTOR FOR ACETYLCHOLINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ANTIADRENERGIC

A

REFERS TO A DRUG BLOCKING A RECEPTOR FOR EPINEPRHINE OR NOREEPINEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BIOAVAILABILITY

A

AMOUNT OF DRUG THAT REACHES THE SYSTEMIC CIRCULATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CNS

A

A system that includes the brain and spinal cord, controlling voluntary and involuntary acts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CHOLINERGIC (CHOLINOMIMETIC)

A

REFERS TO A DRUG CAUSING STIMULATION OF A RECEPTOR FOR ACETLYCHOLINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DRUG ADMINISRATION

A

METHOD BY WHICH THE DRUG IS MADE AVAILABLE TO THE BODY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ED50

A

DOSE AT WHICH A DRUG PRODUCES 50% OF MAXIMAL EFFECT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EFFERENT

A

SIGNALS THAT ARE TRANSMITTED FROM THE BRAIN AND SPINAL CORD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ENTERAL

A

USE OF THE INTESTINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FIRST PASS EFFECT

A

INITIAL METABOLISM IN THE LIVER OF A DRUG TAKEN ORALLY BEFORE THE DRUG REACHES THE SYSTEMIC CIRCULATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GENERIC NAME

A

The name assigned to a chemical by the United States Adopted Name (USAN) Council when the chemical appears to have therapeutic use and the manufacturer wishes to market the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HYPERSENSITIVITY

A

AN ALLERGIC OR IMMUNE MEDIATED REACTION TO A DRUG, WHICH CAN BE SERIOUS, REQUIRING AIRWAY MAMINTANANCE OR VENTILATOR ASSISTANCE

18
Q

IDIOSYNCRATIC EFFECT

A

AN ABNORMAL OR UNEXPECTED REACTION TO A DRUG OTHER THAN AN ALLERGIC REACTION AS COMPARED WITH THE PREDICTED EFFECT

19
Q

INHALATION

A

TAKING A SUBSTANCE, TYPICALLY IN THE FORM OF GASES, FUMES, VAPORS, MISTS,AEROSOLS, OR DUSTS, INTO THE BODY BY BREATHING

20
Q

LD50

A

LETHAL DOSE FOR 50% OF THE POPULATION

21
Q

LOCAL EFFECT

A

LIMITED TO THE AREA OF TREATMENT

22
Q

LUNG AVAILABILITY/ SYSTEMIC AVAILABILITY

A

(L/T RATIO )

AMOUNT OF DRUG THAT IS MADE AVAILABLE TO THE LUNG OUT OF THE TOTAL AVAILABLE TO THE BODY

23
Q

MEDICATION RECONSILIATION

A

The formal process in which healthcare providers work together with patients, families and care providers to ensure accurate and comprehensive medication information is communicated consistently across transitions of care

24
Q

NONPROPRIETARY NAME

A

THE NAME OF A DRUG OTHER THAN ITS TRADEMARKED NAME

25
Q

NOREPINEPHRINE

A

A NATURALLY OCCURING CATECHOLAMINE, PRODUCED BY THE ADRENAL GLAND MEDULLA, THAT HAS PROPERTIES SIMILAR TO THOSE OF EPINEPHRINE.

26
Q

PLACEBO

A

AN INERT SUBSTITUTE, CAUSING NO EFFECT

27
Q

RECEPTOR

A

A CELL COMPONENT THAT COMBINES WITH A DRUG TO A CHANGE OR ENCHANCE THE FUNCTION OF THE CELL

28
Q

STRUCTURE (SAR)

A

SAR- STRUCTURE ACTIVITY RELATION

IS THE RELATIONSHIP BRW A DRUG ‘S CHEMICAL STRUCTURE AND THE OUTCOME IT HAS ON THE BODY

29
Q

SYMPATHOLYTIC

A

AN AGENT BLOCKING OR INHIBITING THE EFECT OF THE SYMPATHETIC NERVOUS SYSTEM

30
Q

SYMPATHOMIMETIC

A

AN AGENT CAUSING STIMULATION OF THE SNS

31
Q

SYNERGISM EFFECT

A

COMINED DRUGS EFFECTS THAT ARE ARE GREATER THATN IF THE DRUGS WERE GIVEN ALONE

32
Q

SYSTEMIC EFFECT

A

PERTAINS TO THE WHOLE BODY, DRUG IS NOT LIMITED TO LOCAL SITE, POSSIBLY CAUSING SIDE EFFECTS

33
Q

TACHYPHYLAXIS

A

A RAPID DECREASE IN RESPONSE TO A DRUG

34
Q

THERAPEUTIC INDEX

A

Difference between the minimal therapeutic and toxic concentrations of a drug; the smaller the difference the greater chance the drug will be toxic
(THE GREATER THE NUMBER THE SAFER THE DRUG)

35
Q

TOLERANCE

A

DESCRIBES A DRECREASING INTENSITY OF RESPONSE TO A DRUG OVER TIME

36
Q

TOPICAL

A

USE OF THE SKIN OR MUCUS MEMBRANE (E.G LOTION )

37
Q

TOXICOLOGY

A

THE STUDY OF TOXIC SUSBTANCES AND THEU PAHRMACOLOGICAL ACTIONS, INCLUDING ANTIDOTES AND POISON CONTROL

38
Q

TRANSDERMAL

A

USE OF THE SKIN (EG PATCH)

39
Q

alpha 1

A

alpha1 receptors vasoconstrict located in vasculature peripheries, kidneys, GI tract

40
Q

alpha 2 receptors

A

causes vasodilation also found in CNS

41
Q

Beta 1

A

excitatory

locates in the heart muscle

42
Q

beta

A

exhibitory (relaxation)

bronchodilator